Gene · 11343
Papers2,780
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,780
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Immunotherapy impact of macrophage glycosylation on cholangiocarcinoma and its prognostic and immune microenvironment significance. | Hum Vaccin Immunother | 2026 | 41800715 | PubTator, text mining | PubMed |
| Maternal docosahexaenoic acid and eicosapentaenoic acid supplementation: effects and mechanisms on lipid metabolism in the offspring. | Front Nutr | 2026 | 41798834 | PubTator, text mining | PubMed |
| Alterations in lipid metabolism and blood profile in gynecological cancers - potential strategies in diagnosis and treatment. | Front Physiol | 2026 | 41778199 | PubTator, text mining | PubMed |
| Construction and initial validation of key gene network for progesterone resistance in endometrial cancer based on genome-wide CRISPR screening. | Sci Rep | 2026 | 41775739 | PubTator, text mining | PubMed |
| MAGL Inhibition Relieves Psoriasiform Inflammation and Pruritus Via Modulation of ALOX12-12-HETE Axis in Mice. | Inflammation | 2026 | 41774275 | PubTator, text mining | PubMed |
| Effects of fatty acids and cholesterol on functions and behavior of bone marrow mesenchymal stem cells. | iScience | 2026 | 41767261 | PubTator, text mining | PubMed |
| Exploratory Proteomic Profiling Reveals Potential Mediators of 5-FU Response under p53 Deficiency in Colon Cancer Cells. | Biomol Ther (Seoul) | 2026 | 41755778 | PubTator, text mining | PubMed |
| Disulfiram and Its Derivatives: An Immortal Phoenix of Drug Repurposing. | Pharmaceuticals (Basel) | 2026 | 41754742 | PubTator, text mining | PubMed |
| Reexamining Fat: Exploring Diversity, Plasticity, Development, Functional Implication, and Therapeutic Options. | Int J Mol Sci | 2026 | 41752060 | PubTator, text mining | PubMed |
| Decoding the Role of Lipid Metabolism and Membrane Dynamics in Melanoma. | Int J Mol Sci | 2026 | 41751850 | PubTator, text mining | PubMed |
| Targeting Fatty Acids in Liver Cancer: Molecular Insights and Drug Approaches. | Biomolecules | 2026 | 41750397 | PubTator, text mining | PubMed |
| Cannabinoids, the Blood-Brain Barrier, and Neurodegeneration: Mechanisms, Dysregulation, and Therapeutic Perspectives. | Biomolecules | 2026 | 41750294 | PubTator, text mining | PubMed |
| Exploring the Endocannabinoid System's Influence on Mammary Tissue and Breast Milk Inflammation in Maternal Chronic Obesity. | Biomolecules | 2026 | 41750272 | PubTator, text mining | PubMed |
| Postural Education in School-Aged Populations: Development and Usability Evaluation of a Mobile Biofeedback App (EduBack). | JMIR Hum Factors | 2026 | 41747198 | PubTator, text mining | PubMed |
| Endocannabinoid Modulation in Headache: Mechanisms, Models, and Translational Therapies. | Cells | 2026 | 41744774 | PubTator, text mining | PubMed |
| MAGL-18c attenuates LPS-induced sepsis-associated liver injury by inhibiting TGF-β/Smad signaling and remodeling medium- and long-chain fatty acid metabolism. | Front Immunol | 2026 | 41727475 | PubTator, text mining | PubMed |
| The crossroads of inflammation and oxidative stress: A review of the interplay between eicosanoids and reactive oxygen species. | Pharmacol Res | 2026 | 41722697 | PubTator, text mining | PubMed |
| Metabolic remodeling and immune evasion in glioblastoma: a focus on serine and lipid networks. | Front Oncol | 2026 | 41710656 | PubTator, text mining | PubMed |
| Advances in neuropsychiatry: From objective diagnostics to mechanism-based therapeutics. | Neurotherapeutics | 2026 | 41702796 | PubTator, text mining | PubMed |
| Altered endocannabinoid system gene expression in inflammatory bowel disease mucosa: New perspectives in inflammatory bowel disease management. | World J Gastrointest Endosc | 2026 | 41700170 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/11343/papers?page=3